Written by: PD Dr. Hans-Peter Dürr | Posted on: 11-22-2021 | Category: HTACan a significant effect remain if we re-analyze it in a subpopulation with lower N?In the benefit assessment of drugs, it may happen that a benefit must be re-examined in a subpopulation, for example if the approval is restricted to a subpopulation which particularly benefits from the treatment. In these ...Read More